In this video Jakob Kather and Mihaela Aldea discuss the criteria that define the EBAI framework, three proposed classes of AI-based biomarkers, methodology used during the building of this framework, validation and performance criteria tailored to each biomarker class, and future perspective in terms of guidance that EBAI offers for developers, clinicians, and regulators.
Produced by the European Society for Medical Oncology
https://www.esmo.org
Produced by the European Society for Medical Oncology
https://www.esmo.org
- Categoria
- Oncology
Commenta per primo questo video.









